Shuang Hao

Health economist at MEB, KI. Also attached to the Health Economics and Policy Research Group at LIME.

I am a health economist at MEB working in the research group led by Mark Clements and the prostate cancer research group at MEB. My projects mainly focus on the economic evaluations of cancer screening, diagnosis and disease management, particularly for prostate cancer and breast cancer in Sweden. I also worked as a consultant (20%) at Stockholm Centre for Health Economics (StoCHE) under Region Stockholm. In addition, I am the coordinator of the working group Health Economics for the Swedish Consortium for Research on Organised Prostate Cancer Testing (OPT). I also support the regional OPT team and the Regional Cancer Center in Stockholm.

I have been in collaboration with researchers from the German Cancer Research Centre (DKFZ) and University of Zurich for modelling prostate cancer screening and assessing cost-effectiveness of the screening programs.

I defended my thesis titled Prostate cancer testing in Sweden: the interplay between cost and effectiveness in early December, 2022 (see also publications between 2020 and 2022). The PhD programme was supervised by Mark Clements (principal), Emelie Heintz, Martin Eklund and Ellinor Östensson.

Supervision

PhD supervision

Daniela Skalt (2024-2028, as main supervisor)

Enoch Yi-tung Chen (2021-2025, as co-supervisor)

Xiaoyang Du (2022-2026, as co-supervisor)

Master supervision

Two master students from the master program Health Economics, Policy and Management (2024-2025)

Other working experiences
Prior to the PhD programme, I had 9-year working experiences in the consulting and pharmaceutical industries.

Education background

PhD Health Economics, MPH Health Economics, MSc Applied Economics, BSc Statistics

Peer-reviewed publication

See publications

Report
Kostnadseffektiviteten av bältrosvaccinering med Shingrix® i Region Stockholm
Nystrand C, *Hao S*, Heintz E, Sparring V. Kostnadseffektiviteten av bältrosvaccinering med Shingrix® i Region Stockholm. Stockholm centrum för hälsoekonomi. Centrum för hälsoekonomi, informatik och sjukvårdsforskning, Region Stockholm, 2023. Rapport 2023:2

Hälsoekonomiska konsekvenser av en utvidgad egenprovtagning för klamydia och gonorré i Region Stockholm: Del 2 – analys av kostnadseffektivitet med en dynamisk epidemiologisk modell.
Stockholm centrum för hälsoekonomi, Centrum för hälsoekonomi, informatik och sjukvårdsforskning, Region Stockholm, 2023. Rapport 2023:5

3196 Global Health Economics (VT2022, VT2024)
K9F3196 Global Health Economics (Planned HT2025, HT2026)